RESOLIAN BIOANALYTICS
Live / Registered — Registered (as of 04 Jun 2024)
What this means for you
Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97796233
- Registration number
- 7410178
- Mark type
- Stylized text
- Filed
- 15 Feb 2023
- Published for opposition
- 09 Jan 2024
- Registered
- 04 Jun 2024
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 042 — Scientific and technological services: Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development
Owner
- Alliance Pharma Inc., Malvern, PA, US
- Alliance Pharma Inc., Malvern, PA, US
- Alliance Pharma Inc., Malvern, PA, US
Prosecution history
- 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Apr 2024 — USE AMENDMENT FILED
- 19 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 05 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jan 2024 — PUBLISHED FOR OPPOSITION
- 20 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE